Cambridge Trust’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $449K | Sell |
3,400
-140
| -4% | -$17.5K | 0.02% | 199 |
|
|
2023
Q4 | $431K | Sell |
3,540
-49
| -1% | -$5.47K | 0.02% | 202 |
|
|
2023
Q3 | $403K | Buy |
3,589
+49
| +1% | +$6.22K | 0.02% | 206 |
|
|
2023
Q2 | $515K | Hold |
3,540
| – | – | 0.02% | 184 |
|
|
2023
Q1 | $457K | Hold |
3,540
| – | – | 0.02% | 193 |
|
|
2022
Q4 | $451K | Sell |
3,540
-197
| -5% | -$22.9K | 0.02% | 206 |
|
|
2022
Q3 | $391K | Sell |
3,737
-36
| -1% | -$3.95K | 0.02% | 214 |
|
|
2022
Q2 | $396K | Sell |
3,773
-155
| -4% | -$18.4K | 0.02% | 222 |
|
|
2022
Q1 | $502K | Sell |
3,928
-252
| -6% | -$30.4K | 0.02% | 218 |
|
|
2021
Q4 | $516K | Buy |
4,180
+2,668
| +176% | +$349K | 0.02% | 223 |
|
|
2021
Q3 | $215K | Hold |
1,512
| – | – | 0.01% | 260 |
|
|
2021
Q2 | $236K | Sell |
1,512
-54
| -3% | -$8.75K | 0.01% | 250 |
|
|
2021
Q1 | $244K | Sell |
1,566
-109
| -7% | -$16.9K | 0.01% | 241 |
|
|
2020
Q4 | $250K | Sell |
1,675
-206
| -11% | -$29.1K | 0.01% | 208 |
|
|
2020
Q3 | $248K | Hold |
1,881
| – | – | 0.01% | 205 |
|
|
2020
Q2 | $238K | Buy |
+1,881
| New | +$217K | 0.01% | 219 |
|
|
2020
Q1 | – | Sell |
-1,999
| Closed | -$291K | – | 280 |
|
|
2019
Q4 | $291K | Sell |
1,999
-29
| -1% | -$4K | 0.02% | 233 |
|
|
2019
Q3 | $270K | Hold |
2,028
| – | – | 0.02% | 230 |
|
|
2019
Q2 | $232K | Sell |
2,028
-11
| -0.5% | -$1.29K | 0.01% | 237 |
|
|
2019
Q1 | $253K | Hold |
2,039
| – | – | 0.02% | 221 |
|
|
2018
Q4 | $205K | Hold |
2,039
| – | – | 0.01% | 228 |
|
|
2018
Q3 | $261K | Buy |
2,039
+20
| +1% | +$2.38K | 0.02% | 221 |
|
|
2018
Q2 | $218K | Buy |
2,019
+27
| +1% | +$2.94K | 0.01% | 233 |
|
|
2018
Q1 | $211K | Hold |
1,992
| – | – | 0.01% | 239 |
|
|
2017
Q4 | $234K | Sell |
1,992
-103
| -5% | -$11.6K | 0.01% | 234 |
|
|
2017
Q3 | $239K | Buy |
+2,095
| New | +$242K | 0.02% | 232 |
|
|
2017
Q2 | – | Sell |
-2,017
| Closed | -$239K | – | 274 |
|
|
2017
Q1 | $239K | Hold |
2,017
| – | – | 0.02% | 248 |
|
|
2016
Q4 | $202K | Hold |
2,017
| – | – | 0.01% | 256 |
|
|
2016
Q3 | $255K | Buy |
+2,017
| New | +$249K | 0.02% | 225 |
|
|
2015
Q2 | – | Sell |
-1,766
| Closed | -$202K | – | 238 |
|
|
2015
Q1 | $202K | Buy |
+1,766
| New | +$201K | 0.02% | 225 |
|
Other funds holding ZBH
Cambridge Trust's ZBH Position: Q1 2024 in Review
Cambridge Trust reduced its Zimmer Biomet (ZBH) stake by 4% in Q1 2024, selling an estimated $17.5K and leaving 3,400 shares worth $449K. The position accounts for 0.02% of the portfolio, ranked #199.
Cambridge Trust first reported a position in ZBH in Q1 2015 and has held it in 30 quarters since. The position peaked at $516K in Q4 2021. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.
- Cambridge Trust held 3,400 shares of Zimmer Biomet worth $449K as of Q1 2024.
- Cambridge Trust sold 140 Zimmer Biomet shares in Q1 2024, an estimated $17.5K.
- Zimmer Biomet made up 0.02% of Cambridge Trust's portfolio in Q1 2024, its #199 holding.
- Cambridge Trust first reported a position in Zimmer Biomet in Q1 2015 and has held it in 30 quarters since.
- Cambridge Trust's Zimmer Biomet position peaked at $516K in Q4 2021.
- 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.